Brokerages Set Relx PLC (LON:REL) PT at GBX 1,899.22
Relx PLC (LON:REL) has received an average rating of “Buy” from the thirteen analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is GBX 1,897.30 ($24.79).
Several analysts have issued reports on REL shares. JPMorgan Chase & Co. increased their target price on shares of Relx from GBX 1,900 ($24.83) to GBX 1,950 ($25.48) and gave the stock an “overweight” rating in a research note on Friday, July 26th. UBS Group restated a “sell” rating on shares of Relx in a research report on Friday, July 26th. Goldman Sachs Group raised their price objective on shares of Relx from GBX 2,123 ($27.74) to GBX 2,178 ($28.46) and gave the company a “buy” rating in a research report on Tuesday, June 11th. Barclays lowered their price objective on shares of Relx from GBX 2,160 ($28.22) to GBX 2,100 ($27.44) and set an “overweight” rating on the stock in a research report on Friday, July 26th. Finally, Deutsche Bank restated a “hold” rating on shares of Relx in a research report on Friday, July 26th.
LON REL traded up GBX 22 ($0.29) on Wednesday, hitting GBX 1,947.50 ($25.45). The stock had a trading volume of 2,602,770 shares, compared to its average volume of 4,990,000. Relx has a 52-week low of GBX 1,466.50 ($19.16) and a 52-week high of GBX 1,995.13 ($26.07). The company has a debt-to-equity ratio of 308.02, a quick ratio of 0.40 and a current ratio of 0.45. The company has a market capitalization of $37.79 billion and a price-to-earnings ratio of 25.26. The firm has a 50-day moving average of GBX 1,937.87 and a 200-day moving average of GBX 1,792.17.
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
See Also: Holder of Record
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.